Presentation by Daniel Laune, CEO & Scientific Director, Kyomed

1. Daniel LAUNE, CEO & Scientific Director

2. - CONFIDENTIAL - 2
Our Services Our DNA
E-Health
• Validation of usages & acceptability
according to a Living Lab methology.
• Evaluation of health benefits of
connected medical devices & apps
• Medical, technological & regulatory
support toward industrialisation
• Implementation of digital care pathway
Data
Mining
• Data collection & storage
• Integration & analysis of heterogeneous
data
• Development of secured and evolutive
databases
• Development of clinical decision
support systems
Biomarkers
• E-Health
• Molecular & digital biomarkers
discovery
• Access to biobanks & cohorts
• Clinical validation
• Identification of biomarker signature &
clinically relevant algorithms
• Private company founded in April 2014
• Fee-for service/Collaboration
• A multidisclinary team
specialized in health
• Accelerate and optimise the development of innovative solutions in the field of personalized medicine
• Facilitate the deployment of new technologies in Europe : adaptation to usages, specific healthcare pathway and
regulatory certifications
• Pilot complex projects by assembling multiple scientific, technical and medical expertises. Kyomed unites the necessary
expertise and accompanies its clients from research to market.

3. - CONFIDENTIAL - 3
Our Assets Our DNA
In the future, diagnostics and medical decisions will integrate not only classical
biochemical, molecular and physiological biomarkers, but also digital markers
collected from connected devices and questionnaires